ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Gene Expression"

  • Abstract Number: 0105 • ACR Convergence 2026

    Gene expression signatures as predictors of response to methotrexate in pediatric non-infectious uveitis (NIU).

    Grant Schulert1, Thuy Do1, Ashley Kuenzi Davis1, Emily Straus1, Abigale Jagger2, Margaret Chang3, Mekibib Altaye4, Virginia Utz1, Hermine Brunner1, Andrew Zeft5, Sunil Srivastava6, Erin Stahl7, Ashley Cooper7, Bharti Nihalani-Gangwani8, Mindy Lo9, Megan Quinlan-Waters1, Alexandra Duell1 and Sheila Angeles-Han10 Affiliations: 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's, Cincinnati, OH, 3Boston Children's Hospital, Newton, MA, 4Cincinnati Children's Hospital, Cincinnati, 5Cleveland Clinic, Cleveland, OH, 6Cole Eye Institute/Cleveland Clinic, Cleveland, OH, 7Children's Mercy Kansas City, Kansas City, MO, 8Boston Children's Hospital, Boston, 9Boston Children's Hospital, Boston, MA, 10Cincinnati Children's Hospital, Cincinnati, OH

    Background/Purpose: Methotrexate (MTX) is the recommended first-line treatment for children with non-infectious uveitis (NIU), with treatment failure rates as high as 50%. Because therapeutic response…
  • Abstract Number: 1329 • ACR Convergence 2026

    Single Nucleus RNA Sequencing of Methylprednisolone Effects Reveals Biomarkers in PsA Synovial Lining Fibroblasts

    Shing Law1, Carla J Cohen2, Sarah Snelling1, Philippa Hulley1 and Jolet Mimpen1 Affiliations: 1Botnar Institute for Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Intra-articular glucocorticoid injections are used to treat RA and PsA. Much is known about glucocorticoid effects but a more detailed understanding of their effects…
  • Abstract Number: 2048 • ACR Convergence 2026

    Unique Type 1 and Type 2 Interferon (IFN) Response Gene Score Longitudinal Changes in Refractory Juvenile Dermatomyositis (JDM) Patients Receiving Baricitinib by Single-Cell RNA Sequencing

    Jessica Simpson1, Vicky Chen2, Adeline Chin3, Ujana Zajmi3, Amy Kaneshiro3, Megan Darrell3, Stephen Brooks3, Faiza Naz3, Robert Colbert4, Lisa Rider5, Stefania dell'Orso3 and Hanna Kim1 Affiliations: 1NIAMS, NIH, Bethesda, MD, 2Integrated Data Sciences Section, National Institute of Allergy and Infectious Diseases Collaborative Bioinformatics Resource, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) / National Institutes of Health (NIH), Bethesda, MD, 4NIH/NIAMS, Bethesda, MD, 5NIEHS, NIH, Garrett Park, MD

    Background/Purpose: JDM is a rare heterogenous systemic autoimmune condition. Though pathogenesis is incompletely understood, dysregulated type I/II IFN signaling is well documented. Patients with refractory…
  • Abstract Number: 0128 • ACR Convergence 2026

    Cellular and Transcriptional Differences Across Early Sjögren’s Disease Subphenotypes

    Marcin Radziszewski1, James Li2, Songyuan Yao1, Cherilyn Pritchett-Frazee1, Mandi Wiley1, Kandice Tessneer1, Caleb Marlin1, Miles Smith1, Kevin Wei3, Soumya Raychaudhuri4, Michael Brenner5, Lam Tsoi6, Johann Gudjonsson7, Nir Hacohen8, Umesh Deshmukh1, Susan Kovats1, Judith James9, R. Hal Scofield1, Astrid Rasmussen1, Stephen Shiboski10, Bhuwan Khatri1, Alan Baer11, A. Darise Farris9, Caroline Shiboski10, Joel Guthridge9, Blake M. Warner12 and Christopher Lessard9 Affiliations: 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Camus and Oklahoma Medical Research Foundation, Edmond, OK, 3Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5Brigham and Women's Hospital, Harvard Medical School, Newton, MA, 6University of Michigan School of Public Health, Ann Arbor, MI, 7University of Michigan, Ann Arbor, MI, 8Broad Institute, Boston, 9Oklahoma Medical Research Foundation and University of Oklahoma Health Campus, Oklahoma City, OK, 10University of California San Francisco, San Francisco, CA, 11Johns Hopkins University School of Medicine, Baltimore, MD, 12National Institutes of Health, Bethesda, MD

    Background/Purpose: Sjögren's Disease (SjD) lacks an established definition of early disease. To study early disease mechanisms, the Sjögren's Team for Accelerating Medicines Partnership (STAMP) defined…
  • Abstract Number: 1525 • ACR Convergence 2026

    Transcriptomic Profiling Reveals Biologically Distinct Subgroups in Newly Diagnosed Children and Adolescents with Systemic Lupus Erythematosus

    Reagan Reid1, Isha Datar2, Huayun Hou2, Daniela Dominguez3, Andrea Knight4, Deborah Levy5, Lawrence Ng6, Zhaoyu Ding7, Michael Wilson2, Lauren Erdman8, Eleanor Pullenayegum2 and Linda Hiraki5 Affiliations: 1University of Toronto, Toronto, ON, Canada, 2SickKids Research Institute, Toronto, Canada, 3The Hospital for Sick Children, Toronto, Canada, 4Hospital for Sick Children, Toronto, ON, Canada, 5The Hospital for Sick Children, Toronto, ON, Canada, 6The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 7Genetics & Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada, 8Cincinnati Children's Hospital, Cincinnati

    Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) is a heterogeneous disease both clinically and genetically. Using treatment-naïve gene expression profiles, we aimed to identify homogenous transcriptomic…
  • Abstract Number: 2057 • ACR Convergence 2026

    Distinct Clonal Expansions of GZMB+ CD8+ Terminally Differentiated Effector Memory T (TEMRA) Cells Characterize Blood of Inclusion Body Myositis Patients

    Raphael Kirou1, Iago Pinal-Fernandez2, Maria Casal-Dominguez2 and Andrew Mammen3 Affiliations: 1Weill Cornell Medical College, New York, NY, 2NIAMS/National Institutes of Health, Bethesda, MD, 3NIH, Bethesda, MD

    Background/Purpose: Inclusion body myositis (IBM) is an inflammatory myopathy of unclear etiology. Previous studies using flow cytometry and spectratyping have identified clonal populations of cytotoxic…
  • Abstract Number: 0134 • ACR Convergence 2026

    Molecular Characterization of Heterogeneity in Sjögren’s Disease and Non-Sjögren’s Sicca Syndrome

    James Li1, Bhuwan Khatri2, Songyuan Yao2, Marcin Radziszewski2, Cherilyn Pritchett-Frazee2, Mandi Wiley2, Kandice Tessneer2, Christina Lawrence2, Hope Christakos2, Charmaine Lopez-Davis3, Tommi C. Taylor4, Michelle L. Joachims5, Astrid Rasmussen2, R. Hal Scofield2, He Li6, Blake M. Warner7, Judith James8, Joel Guthridge8, A. Darise Farris8, Kathy Sivils9 and Christopher Lessard8 Affiliations: 1University of Oklahoma Health Camus and Oklahoma Medical Research Foundation, Edmond, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3University of Oklahoma Health Campus and Oklahoma Medical Research Foundation, Oklahoma City, OK, 4University of Oklahoma Health Campus and Oklahoma Medical Research Foundation, Oklahoma City, 5Oklahoma Medical Research Foundation, Oklahoma City, 6JNJ, North Wales, PA, 7National Institutes of Health, Bethesda, MD, 8Oklahoma Medical Research Foundation and University of Oklahoma Health Campus, Oklahoma City, OK, 9Johnson and Johnson, Edmond, OK

    Background/Purpose: Sjögren's disease (SjD) is a clinically and molecularly heterogeneous systemic autoimmune disease. Anti-Ro negative (anti-Ro-) SjD patients are underrepresented in research studies and often…
  • Abstract Number: 1573 • ACR Convergence 2026

    Automated Synovial Mast Cell Quantification Reveals Associations with Pain, Obesity and Interferon Related Inflammation in Osteoarthritis

    Xiaoshun Li1, Daniel Ramirez2, Edward Dicarlo2, Peter Sculco2, Jose Rodriguez1, Rogelio Perez3, Elizabeth Onoprishvili2, Shady Younis4, Eun Song5, William Robinson6, Miguel Otero2, Dana Orange7 and Bella Mehta8 Affiliations: 1Hospital For Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, 3Weil Cornell Medicine, New York, 4Standford University, Palo Alto, 5Stanford University, Palo Alto, 6Stanford University, Palo Alto, CA, 7Rockefeller University, New York, 8Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Mast cells have been implicated in the pathogenesis of osteoarthritis (OA) [1]. We hypothesized that mast cell infiltration in synovial tissue may contribute to…
  • Abstract Number: 2058 • ACR Convergence 2026

    Peripheral Blood Transcriptomics Reveals a Distinct Immune Network Architecture in Anti-MDA5 Dermatomyositis

    Yoshinobu Koyama1, Yoshiharu Sato2, Miku Nishihara1, Yoshinori Nishiura1 and Yu Nakai1 Affiliations: 1Division of Rheumatology, Center for Autoimmune Diseases, Japanese Redcross Okayama Hospital, Okayama, Japan, 2DNA Chip Research Inc., Medical Laboratory, Kawasaki, Japan

    Background/Purpose: Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5-DM) is a severe subtype of idiopathic inflammatory myopathy (IIM) characterized by rapidly progressive interstitial lung disease and…
  • Abstract Number: 0264 • ACR Convergence 2026

    Distinct Multi-omic Signature Predicts Post-MMF Withdrawal Flares in Systemic Lupus Erythematosus Patients

    Rufei Lu1, Benjamin Jones1, Miles Smith1, Carla Guthridge1, Christian Wright1, Susan Macwana1, Catriona Wagner1, Eliza Chakravarty1, Wade DeJager1, Jeanette Smith1, Tammy Utset2, Diane Kamen3, Gabriel Nicolas Contreras Martin4, William McCune5, Cynthia Aranow6, Kenneth Kalunian7, Elena Massarotti8, Megan Clowse9, Brad Rovin10, S. Sam Lim11, Vikas Majithia12, Maria Dall'Era13, Richard Looney14, Doruk Erkan15, Amit Saxena16, Nancy Olsen17, Kichul Ko18, Ellen Goldmuntz19, William Barry20, Ashley Pinckney21, Judith James22 and Joel Guthridge22 Affiliations: 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Chicago, Chicago, IL, 3Medical University of South Carolina, Johns Island, SC, 4University of Miami, Key Biscayne, FL, 5U Michigan, Ann Arbor, MI, 6Feinstein Institutes for Medical Research, Manhasset, NY, 7UC San Diego, La Jolla, CA, 8Brigham and Women's Hospital, Boston, MA, 9Duke University, Chapel Hill, NC, 10Ohio State University, Columbus, OH, 11Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 12Mayo Clinic Florida, Jacksonville, FL, 13UCSF, Corte Madera, CA, 14University of Rochester, Rochester, NY, 15Hospital for Special Surgery, New York, NY, 16NYU Grossman School of Medicine, New York, NY, 17Penn State University/Milton S Hershey, Hershey, PA, 18The University of Chicago, Chicago, IL, 19NIAID/ NIH, Washington, DC, 20Rho, Inc, Durham, NC, 21Rho Federal Systems, St. Louis Park, MN, 22Oklahoma Medical Research Foundation and University of Oklahoma Health Campus, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) typically follows a relapsing-remitting course. Mycophenolate mofetil (MMF) is a cornerstone therapy for SLE, yet long‑term use is limited by…
  • Abstract Number: 1646 • ACR Convergence 2026

    Blood transcriptome and serum protein biomarkers associated with tophaceous gout

    Austin Wheeler1, Ana Vazquez2, Jeffrey Edberg3, Angelo Gaffo3, Michael Duryee1, James O'Dell1, Jeff Newcomb1, Michael Pillinger4, Robert Terkeltaub5, Ryan Ferguson6, Tuhina Neogi7, Bryant England1, Tony Merriman8, Richard Reynolds3 and Ted Mikuls1 Affiliations: 1University of Nebraska Medical Center, Omaha, NE, 2Michigan State University, East Lansing, MI, 3University of Alabama at Birmingham, Birmingham, AL, 4New York University Grossman School of Medicine, New York, NY, 5Retired, San Diego, CA, 6VA Boston Cooperative Studies Program Coordinating Center, Boston, MA, 7Boston University School of Medicine, Boston, MA, 8University of Alabama at Birmingham, Homewood, AL

    Background/Purpose: In gout, the presence of tophi has important clinical implications, including associations with increased functional impairment and mortality and a lower likelihood of achieving…
  • Abstract Number: 2066 • ACR Convergence 2026

    A Genome-Scale, In Vivo Transcription Factor Screen Identifies a Previously Unrecognized Factor That Enhances CAR-T Persistence and Tumor Control Under High-Dose Rechallenge

    Xiaoyu Zhou1, Jiabiao Hu1, Yixuan Zhou1, Aijun Ti1, Lina Zhou1, Tianying Chen1, Xu Feng1, Yuan Liu1, Hao Wang1, Qi Zhang1, Peng Zhang1, George Church2 and Luhan Yang1 Affiliations: 1Qihan Biotechnology, Hangzhou, China, Hangzhou, China (People's Republic), 2Department of Genetics, Harvard Medical School, Boston, United States, Boston

    Background/Purpose: Chimeric antigen receptor (CAR)-T cell therapy holds great promise for cancer and a growing range of immune-mediated diseases, but responses are not always durable,…
  • Abstract Number: 0443 • ACR Convergence 2026

    Characterizing the mode of action of the oral TNFR1 signal inhibitor, balinatunfib, in rheumatoid arthritis

    Xuan Wang1, Jan Wiemer2, Kasum de Souza Mateus Azim3, Kai Liu1, Donald Jackson4, Subhadeep Das5, Christian Asbrand3, Anna Fishbein6, Markus Kohlmann7, Seoyoung Kim8, Maria Wiekowski6, Ernest Choy9 and Rui Wang4 Affiliations: 1Sanofi, Suzhou, China, Suzhou, 2Sanofi, Berlin, Germany, Berlin, 3Sanofi, North Rhine-Westphalia, Germany, North Rhine-Westphalia, 4Sanofi, Cambridge, MA, USA, Cambridge, 5Sanofi, Telangana, India, Telangana, 6Sanofi, Morristown, NJ, USA, Morristown, 7Sanofi, Frankfurt, Germany, Frankfurt, 8Sanofi, Cambridge, MA, USA, Cambridge, MA, 9Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre at Cardiff University School of Medicine, Cardiff, Wales, UK, Cardiff

    Background/Purpose: Balinatunfib (SAR441566) is a first-in-class oral small molecule that selectively inhibits pro-inflammatory TNFR1-mediated signaling while preserving TNFR2-mediated signaling important for immune homeostasis. Here, we…
  • Abstract Number: 1962 • ACR Convergence 2026

    An Integrated Multi-Agent System for Accelerating Rheumatology Research

    Michael Whitfield1, Zhiyun Gong2, Chanhyuk Park3 and Patricia Pioli1 Affiliations: 1Geisel School of Medicine at Dartmouth, Lebanon, NH, 2Dartmouth College, Lebanon, NH, 3Geisel School of Medicine at Dartmouth, West Lebanon, NH

    Background/Purpose: Rheumatology research requires continuous literature surveillance, analysis of multidimensional data across fragmented tools, and integration of datasets from different platforms, which are generated faster…
  • Abstract Number: 2084 • ACR Convergence 2026

    Immunometabolic changes associated with sustained remission in patients with SLE and JDM treated with anti-CD19 CAR-T cells

    Emiliano Marasco1, Andrea Ariolli2, Nina De Franco2, Rebecca Nicolai3, Claudia Bracaglia2, Marco Becilli4, Pietro Merli4, Maria I. Petrone2, Francesca Del Bufalo4, Mattia Algeri4, Maria G. Cefalo4, Concetta Quintarelli5, Franco Locatelli4 and Fabrizio De Benedetti6 Affiliations: 1Division of Rheumatology, Bambino Gesù Children's Hospital, Manhosset, NY, 2Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 3Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesu', Rome, Italy, Rome, Lazio, Italy, 4Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 5Department of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy, 6Bambino Gesu Children's Hospital, Rome, Rome, Italy

    Background/Purpose: Anti-CD19-CAR T-cell therapy is an innovative strategy to induce profound B cell depletion in patients with refractory autoimmune diseases, allowing to reach a sustained…
  • 1
  • 2
  • 3
  • …
  • 37
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology